drugset

drugset / Trial / NCT00325780

Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

NCT00325780 ↗

Phase 3 Completed 1355 enrolled Kowa Research Europe

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is a long-term follow-up protocol for patients who participated in study NK-104-3.01EU or study NK-104-3.02EU.

Timeline

Start: 2006-07
Primary completion: 2007-11
Completion: 2007-11

Publications

Ose L, Budinski D, Hounslow N, Arneson V. Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia. Atherosclerosis. 2010 May;210(1):202-8. doi: 10.1016/j.atherosclerosis.2009.12.009. Epub 2009 Dec 11.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pitavastatin	Small molecule	4 mg	—

Indications